Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients - Concepedia

Concepedia

Publication | Open Access

Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients

DOI Full Paper Access

98

Citations

39

References

2015

Year

Gaojie Liu, Jie Zhu, Menglei Yu, Canfeng Cai, Yu Zhou, Min Yu, Zhiqiang Fu, Yuanfeng Gong, Bin Yang, Yingru Li,

Journal of Translational Medicine

Abstract

These results indicate that GDH plays a critical role in CRC progression, and may provide a novel metabolism therapeutic target for CRC treatment.

References

	Year	Citations

Page 1